32 phenotypes from 2 alleles in 6 genetic backgrounds

Allelic Composition Genetic Background	Annotated Term	Reference
Cd59atm1Bpm/Cd59atm1Bpm B6.129-Cd59atm1Bpm	abnormal CD4-positive, alpha-beta T cell physiology	J:119703, J:123582
	abnormal complement pathway	J:92414
	abnormal humoral immune response	J:119703
	choroidal neovascularization	J:143638
	decreased B cell proliferation	J:119703
	decreased grip strength	J:113567
	decreased IgG level	J:119703
	decreased plasma cell number	J:119703
	decreased susceptibility to Poxviridae infection	J:122201
	increased CD4-positive, alpha-beta T cell number	J:123582
	increased double-positive T cell number	J:123582
	increased neutrophil cell number	J:123582
	increased renal tubule apoptosis	J:92414
	increased susceptibility to experimental autoimmune myasthenia gravis	J:113567
	increased susceptibility to kidney reperfusion injury	J:92414
	increased susceptibility to Orthomyxoviridae infection	J:123582
	increased T cell proliferation	J:122201
	lung inflammation	J:123582
	myositis	J:113567
	pulmonary fibrosis	J:123582
Cd59atm1Bpm/Cd59atm1Bpm involves: 129	abnormal complement pathway	J:148367
	abnormal Wallerian degeneration	J:148367
	increased macrophage cell number	J:148367
	increased susceptibility to induced arthritis	J:146711
	increased susceptibility to injury	J:148367
Cd59atm1Bpm/Cd59atm1Bpm involves: 129 * BALB/c	increased susceptibility to Orthomyxoviridae infection	J:123582
	increased susceptibility to weight loss	J:123582
Cd59atm1Bpm/Cd59atm1Bpm involves: 129 * C57BL/6	demyelination	J:89014
	increased susceptibility to experimental autoimmune encephalomyelitis	J:89014
Cd59atm1Bpm/Cd59atm1Bpm involves: 129/Sv * C57BL/6	decreased body weight	J:70419
	hemoglobinemia	J:70419
	hemoglobinuria	J:70419
	increased erythrocyte osmotic fragility	J:70419
	reticulocytosis	J:70419
Cd59atm1Song/Cd59atm1Song involves: 129S6/SvEvTac	abnormal complement pathway	J:76578